We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The profiles provide an overview of data on cardiovascular and cardiovascular related conditions of heart disease, stroke, diabetes and kidney disease. Data will be available for England, integrated care boards and upper tier local authorities where available.
Caution is required if prescribing febuxostat in patients with pre-existing major cardiovascular disease, particularly, in those with evidence of high urate crystal and tophi burden or those initiating urate-lowering therapy.…
Report by the Committee on the Medical Effects of Air Pollutants describing how long-term exposure to ambient air pollution can lead to cardiovascular disease.
…Findings from a phase 4 clinical study (the CARES study) in patients with gout and a history of major cardiovascular disease show a higher risk for cardiovascular-related death and for all-cause mortality in patients assigned to febuxostat than in those assigned to allopurinol.
Systematic reviews and meta-analyses of randomised controlled trials have highlighted a dose-dependent increased risk of atrial fibrillation in patients with established cardiovascular diseases or cardiovascular risk factors treated with omega-3-acid ethyl ester medicines compared to placebo…
Estimates of the cardiovascular disease events and costs avoided from increasing blood pressure checks in community pharmacies in England.
A report by the Committee on the Medical Effects of Air Pollutants (COMEAP).
A professional resource on improving the detection and treatment of the high-risk conditions atrial fibrillation, high blood pressure and high cholesterol
Evidence and guidance to help healthcare professionals to prevent heart attacks, strokes and dementia and to improve cardiovascular health.
Advice to local authority and NHS commissioners and providers about actions to improve cardiovascular disease outcomes.
First published during the 2010 to 2015 Conservative and Liberal Democrat coalition government
Using managed clinical networks to improve care of people with high blood pressure (hypertension), stroke, chronic heart disease and diabetes.
Provides advice to local authority and NHS commissioners and providers about actions to improve cardiovascular disease outcomes.…
Facts, resources and information on major public health issues for public health professionals, local authorities and CCG commissioners.
Aceclofenac is now contraindicated in patients with certain established cardiovascular diseases.…
Data and analysis of cardiovascular disease (CVD) prevalence, variation, treatment and outcomes in the Hull CCG area.
Data and analysis of cardiovascular disease (CVD) prevalence, variation, treatment and outcomes in the Enfield CCG area.
Data and analysis of cardiovascular disease (CVD) prevalence, variation, treatment and outcomes in the Croydon CCG area.
Data and analysis of cardiovascular disease (CVD) prevalence, variation, treatment and outcomes in the Medway CCG area.
Data and analysis of cardiovascular disease (CVD) prevalence, variation, treatment and outcomes in the Somerset CCG area.
Data and analysis of cardiovascular disease (CVD) prevalence, variation, treatment and outcomes in the Luton CCG area.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).